Integra Lifesciences Holdings Corp reports results for the quarter ended December 31 - Earnings Summary

Integra LifeSciences Holdings

25/02/2025 14:32

Integra Lifesciences Holdings Corp IART.OQ reported quarterly adjusted earnings of 97 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 89 cents.  The mean expectation of twelve analysts for the quarter was for earnings of 86 cents per share. Wall Street expected results to range from 83 cents to 87 cents per share.

Revenue rose 11.5% to $442.65 million from a year ago; analysts expected $445.15 million.

Integra Lifesciences Holdings Corp's reported EPS for the quarter was 25 cents​.

The company reported quarterly net income of $19.44 million.

Integra Lifesciences Holdings Corp shares had fallen by 2.8% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 0.1% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 7 "hold" and 4 "sell" or "strong sell."

The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Integra Lifesciences Holdings Corp is $24.50

This summary was machine generated from LSEG data February 25 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
0.86
0.97
Beat
Sep. 30 2024
0.39
0.41
Beat
Jun. 30 2024
0.62
0.63
Beat
Mar. 31 2024
0.55
0.55
Met